Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at MK-2870 for non small cell lung cancer (MK-2870-007)

Overview

Cancer types:

Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers

Status:

Open

Phase:

Phase 3

Details

This trial is comparing the combination of MK-2870 and pembrolizumab with pembrolizumab on its own for non small cell lung cancer.

It is open to people with non small cell lung cancer that has spread to another part of the body.

Recruitment start: 20 June 2024

Recruitment end: 27 April 2026

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Eleni Karapanagiotou

Supported by

Merck, Sharp & Dohme LLC

Last reviewed: 16 July 2025

CRUK internal database number: 19888

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.